Plasma plasminogen activator inhibitor-1 as a predictive marker of type 2 diabetic nephropathy in Egyptian patients

Plasma plasminogen activator inhibitor-1 as a predictive marker of type 2 diabetic nephropathy in Egyptian patients

Background The study investigates the relationship between Plasminogen activator inhibitor-1 (PAI-1) levels and the progression of diabetic nephropathy (DN). The fibrinolytic system is impaired in type 2 diabetes mellitus (DM), leading to elevated PAI-1 levels, increasing the potential for renal fib...

Cur síos iomlán

Sonraí bibleagrafaíochta
Príomhchruthaitheoirí: El-Saeid M.E.-S. El-Bawab, Mostafa M.M. Alomairi, Ashraf M. El- Kabeer, Sayed F.A. Abd-Allah
Formáid: Alt
Teanga:English
Foilsithe / Cruthaithe: Wolters Kluwer Medknow Publications 2023-07-01
Sraith:Al-Azhar Assiut Medical Journal
Ábhair:
diabetic nephropathy
end-stage renal disease
fibrinolytic system
plasminogen activator inhibitor-1
renal fibrosis
type 2 diabetes mellitus
Rochtain ar líne:https://journals.lww.com/10.4103/azmj.azmj_22_24

Ar líne

https://journals.lww.com/10.4103/azmj.azmj_22_24

Míreanna comhchosúla